Business Context and Reporting Period
This Form 8-K is a Current Report filed by Bristol-Myers Squibb Company on January 11, 2021. The filing serves to disclose a Regulation FD event where the Company posted an investor presentation to its website. The presentation is attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a conduit for an external presentation rather than a financial statement itself.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The report solely references the availability of an investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The Company provided an investor presentation dated January 11, 2021, which likely contains guidance and outlook, but the specific content is not included in this filing text.
Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities thereof. It shall not be incorporated by reference into any other filing.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Presentation) for specific financial guidance and strategic outlook.
- Verify the content of the presentation on the Company's official investor relations website.
- Note that the presentation materials are not legally "filed" for liability purposes under the Exchange Act.
- Confirm the trading symbols for the Company's registered securities: Common Stock (BMY), 1.000% Notes due 2025 (BMY25), 1.750% Notes due 2035 (BMY35), and Contingent Value Rights (BMY RT, CELG RT).